Restylane Contour Gets FDA Approval for Temple Hollowing
NewBeauty Facebook Pinterest Instagram Youtube find a doctor Face Adult Acne Antioxidants Anti-Aging Celebrity Chronic Skin Conditions Eye Hydration Hyperpigmentation Makeup View All Eyebrows Eye Color Foundation Fragrance Lip Color Makeovers Male Skin Care Peels Pre-Event Prep Retinoids Sensitive Skin Skin Care Skin Health Smile Sun Care Treatments Fillers Microneedling Post-Procedure Skin Care Neurotoxins Regenerative Aesthetics Skin Lifting Body Body Sculpting Breasts Butts Cellulite Hair Removal Hands + Nails Legs Pregnancy Find a Doctor Hair Bond Repair Celebrity Dry Hair Frizzy Hair Gray Hair Hair Color Hair Growth Hair Repair Scalp Health Styling + Tips Awards NB100 Awards 15th Annual Beauty Awards 2025 NewBeauty Readers’ Choice Awards Shopping Gift Guides Product Reviews NewBeauty Storefront Wellness Fitness GLP-1s Health Menopause About Us TESTTUBE Search for: Search HomeWellnessGLP-1s Restylane Contour Gets FDA Approval for Temple Hollowing A new indication brings the upper face into focus. Tatiana Bido Published: Mar 25, 2026 Unsplash / Lance Reis Temples are not usually the first place patients point to when they think about aging, but they may be one of the first places it shows up. Restylane Contour is now FDA-approved for the correction of temple hollowing, expanding beyond its original use in the cheeks and midface. It gives injectors another option to treat an area that quietly affects how the entire face looks and feels. According to a Galderma press release, clinical data showed visible improvement by three months, with results lasting up to 18 months and high patient satisfaction. “As rates of medication-driven weight loss expand, we’re seeing greater need for treatments that can address associated facial volume changes,” said Bill Andriopoulos, PhD, head of global medical affairs at Galderma.